The global disease management apps market size was valued at USD 8.7 billion in 2022 and is expected to grow at a compound annual growth rate(CAGR) of 12.3% from 2023 to 2030. The increasing prevalence of chronic disorders coupled with rising consumer awareness about healthy lifestyle is the major factor driving the global disease management apps market. Moreover, the increasing usage of disease management applications in monitoring disease status and symptoms monitoring is another factor facilitating global market. Also, an integration of healthcare with information technology solutions and rising number of market participants launching apps for management of chronic conditions like heart conditions, diabetes is further augmenting market growth.
The increasing promotion to adopt disease management applications by the government and private organizations owing to certain advantages offered by these apps in monitoring and improving health is projected to facilitate market uptake in coming years. For instance, CDC mobile app developed by CDC is a great application for managing conditions at home and is available on android and iOS platforms. Moreover, increasing number of disease monitoring applications and continuous improvements in the apps quality by the developers is another factor projected to cater market uptake in coming years. For instance, in June 2022, BrightInsight announced the launch of new disease management solution that include healthcare provider interface and analytics, patient apps, and interactive dashboard to advance symptom management and patient engagement.
Moreover, the increasing interest of users to use disease management apps is projected to upsurge the adoption of these apps. Moreover, increasing recommendations from healthcare professionals to use digital applications for better patient care is another factor accelerating the demand for disease management apps. For instance, according to Stanford Medicine Survey conducted in January 2020, the healthcare professionals are preferring mobile applications and telehealth tools to provide quality care to their patients.
Furthermore, the integration of telemedicine and telehealth into disease management apps is gaining higher traction thereby allowing patients to connect with health professionals remotely. Market participants incorporating machine learning and AI into their mhealth applications to offer personalized recommendations and improve health outcomes, they are also integrating wearable technology, like smartwatches and fitness trackers into disease management applications to provide a detail view of patient’s health. For instance, in November 2022 H2o Therapeutics received 510(k) marketing clearance from the U.S. FDA for its prescription mobile application Parky for management of Parkinson’s disease. This app monitors the disease symptoms in real time using apple watch.
COVID-19 pandemic has boosted the adoption of mhealth and disease management apps owing to highest number of downloads in 2020. Government initiatives to promote applications for self-monitoring, inclination towards preventive healthcare, higher demand for telemedicine, and increased products launches by mhealth companies have given momentum to the market. The market will continue to witness robust opportunities owing to higher preference for remote patient monitoring, higher consumer demand for wearables and smart applications, and technological advancements.
The smartphones segment dominated the market with a share of 50.8% in 2022 and is likely to maintain its dominance throughout the forecast period. Constant product developments in terms of features and functions, rising inclination for fitness tracking, health monitoring, and increasing demand for advanced products are anticipated to boost demand for smartphones in the forecast period. Moreover, manufacturers have introduced smartphones to monitor certain vitals like heart rate and breathing rate is also fueling segment uptake. For instance, in February 2021 Google expanded its offering into health tracking using smartphone cameras to monitor respiratory and heart rates. Such novel initiatives in the segment allows disease control in an efficient way.
Wearables segment is anticipated to witness lucrative growth opportunities owing to increased adoption of wearable products among consumers and increased efforts from market players to introduce wearables with advanced monitoring features. For instance, companies such as Samsung, Noise, Fitbit, Fossil Group, Inc. are introducing novel wearable products.
The android segment held the largest share of 51.8% in 2022 and is anticipated to grow at a steady rate during the projected period. The largest revenue share of the segment is accounted to the rising numbers of android users especially in developing countries and rising penetration of telemedicine in countries like China and India. In addition, technological advancements in android apps, convenience of usage, and rising awareness of digital health among people are expected to further fuel segment uptake in coming years.
The iOS segment held the second largest revenue of the market, and the robust growth of the segment is accounted to the increasing penetration of apple products in developed as well as developing economies, increasing demand for smart medical devices incorporated with health apps, and higher standards of privacy and curated content in iOS platforms. Moreover, higher product downloads and rising product introductions for iOS platforms is another factor pushing global market forward. For instance, in June 2021 Apple advanced its personal health capabilities by introducing secure sharing of health information to physicians to get insights on health trends.
The obesity segment was the leading segment in 2022 with a share of 26.5% and its high market growth is attributed to high burden of obesity across the world and availability of large number of apps offering diet management and workout plans. According to WHO, over 650 million population is obese. The obesity management apps help to track things such as, workout tracking, calorie intake monitoring, and also provide certain guidelines for day-to-day activities. Furthermore, rising awareness about fitness, healthy eating and high social media penetration are also augmenting demand for obesity management applications. Some of the major obesity management apps include, PlateJoy, Noom, and WW app.
The rising concerns about mental health, significant demand for effective and efficient mental health management system, and advantageous features of mental health applications personalized care plans, and health data analysis are responsible for higher revenue share of the mental health segment. Furthermore, rising urbanization, changing lifestyle and growing demand for stress management solutions are further propelling segment uptake.
North America led the overall disease management apps market in 2022 with a share of 38.3% and is anticipated to dominate global market throughout the forecast period. Factors such as rising awareness among people to adopt mhealth and digital health applications, high internet, and smartphones penetration, rise in geriatric population and high presence of large number of market participants in North America are driving regional market. Moreover, rising promotion by the healthcare professionals to adopt medical health solutions is further escalating the adoption of disease management apps in the region.
Asia Pacific is anticipated to witness lucrative CAGR throughout the forecast period and its robust growth is accounted to the government initiatives to promote uptake of mhealth and other disease management applications. For instance, Digital India movement transformed the incorporation of IT in every major sectors including healthcare. Moreover, rising burden of target diseases, and significant increase in demand for fitness and health tracking apps in region is likely to support region expansion. For instance, myBupa, Healthengine, AIA Vitality Australia, PhysiApp among others are some of the most downloaded health applications in Australia.
Key players are adopting strategies such as new product development, merger & acquisition, and partnership to increase their market share. Market players such as Fitbit LLC., Healthy.io.Ltd, MyFitnessPal, Inc. and others are actively involved in the development of next generation and advanced disease management apps. For instance, in Jsanuary 2023 Teladoc Health launched an integrated heath application for easy access to patients as well as healthcare professionals. Some of the prominent players in the disease management apps market include:
Fitbit LLC.
Healthy.io.Ltd
MyFitnessPal, Inc.
Noom, Inc.
Azumio Inc.
Medisafe
Sleep Cycle
Curable, Inc
Bearable Ltd
Omada Health Inc.
Report Attribute |
Details |
Disease management apps market size in 2023 |
USD 9.9 billion |
Revenue forecast in 2030 |
USD 22.4 billion |
Growth rate |
CAGR of 12.3% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Platform type, device, indication, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Norway; Sweden; India; China; Japan; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; Saudi Arabia; UAE; South Africa; Kuwait |
Key companies profiled |
Fitbit LLC.; Healthy.io.Ltd; MyFitnessPal, Inc., Noom, Inc.; Azumio Inc.; Medisafe; Sleep Cycle; Curable, Inc; Bearable Ltd; Omada Health Inc. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global disease management apps market report on the basis of platform type, device, indication, and region:
Platform Type Outlook (Revenue, USD Million, 2018 - 2030)
iOS
Android
Others
Device Outlook (Revenue, USD Million, 2018 - 2030)
Smartphones
Tablets
Wearables
Indication Outlook (Revenue, USD Million, 2018 - 2030)
Obesity
Cardiovascular Issues
Mental Health
Diabetes
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global disease management apps market size was estimated at USD 8.7 billion in 2022 and is expected to reach USD 9.9 billion in 2023.
b. The global disease management apps market is expected to grow at a compound annual growth rate of 12.3% from 2023 to 2030 to reach USD 22.4 billion by 2030.
b. North America accounted for the largest share of the disease management apps market in 2022 with a share of 38.3% and is anticipated to dominate the global market throughout the forecast period. Factors such as rising awareness among people to adopt mhealth and digital health applications, high internet, and smartphone penetration, rise in the geriatric population, and high presence of a large number of market participants in North America are driving the regional market.
b. Some key players in the disease management apps market include Fitbit LLC., Healthy.io.Ltd, MyFitnessPal, Inc., Noom, Inc., Azumio Inc., Medisafe, Sleep Cycle, Curable, Inc, Bearable Ltd, and Omada Health Inc.
b. The increasing prevalence of chronic disorders, coupled with rising consumer awareness about healthy lifestyles, is the major factor driving the global disease management apps market. Moreover, the increasing usage of disease management applications in monitoring disease status and symptoms monitoring is another factor facilitating the global market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."